AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7755228
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g of alcohol
Trial: 21790621
Drug: Liberal transfusion
RxNorm normalized name: dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liberal transfusion strategy (RBCs if Hb concentration was 95 g/L or less during CPB and less than 100 g/L postoperatively)
Trial: 17981847
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (5 hours/week for 12 weeks)
Trial: 17981847
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (2 hours/week for 12 weeks)
Trial: 27599039
Drug: IMM-101 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMM-101 (10 mg/ml intradermally) + GEM (1000 mg/m² intravenously)
Trial: 25409371
Drug: Oral diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diet initiated 72 hours after presentation (on-demand group)
Trial: 18829392
Drug: MLN0002 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLN0002 0.5 mg/kg
Trial: 7361704
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg thiamin hydrochloride
Trial: 25543425
Drug: Dog days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dog days moxibustion plaster therapy
Trial: 25543425
Drug: Beclometasone dipropionate
RxNorm normalized name: Beclometasone dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Beclometasone dipropionate aqueous nasal spray
Trial: 20938662
Drug: R-CHOP treatment
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP treatment in IDO-positive DLBCL
Trial: 20938662
Drug: R-CHOP treatment
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP treatment in IDO-negative DLBCL
Trial: 10517729
Drug: Enoxaparin (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (initial 30 mg intravenous bolus followed by 1.0 mg/kg every 12 hours; outpatient phase: 40 mg for patients <65 kg and 60 mg for patients ≥65 kg)
Trial: 10517729
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) for ≥3 days followed by subcutaneous placebo injections
Trial: 363977
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of clomipramine given three times a day
Trial: 24029539
Drug: Short-term group
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term group therapy (20 weekly, 90 min sessions)
Trial: 21890888
Drug: rFVIIa (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rFVIIa (10 μg/kg)
Trial: 21890888
Drug: rFVIIa (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rFVIIa (20 μg/kg)
Trial: 19278128
Drug: Nicotine polacrilex
RxNorm normalized name: Nicotine Polacrilex
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine polacrilex (6 mg)
Trial: 15250816
Drug: Manualized therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manualized therapies
Trial: 8845601
Drug: Calcium augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium augmentation (1700 mg)
Trial: 8845601
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) with dietary calcium augmentation
Trial: 28119138
Drug: Kg‐Free intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kg‐Free intervention (10 weekly group sessions plus 2 booster fortnightly sessions, 2h30 each)
Trial: 25938187
Drug: Mindfulness and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness and acceptance-based group therapy (MAGT)
Trial: 23337838
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy for 8 months
Trial: 22002336
Drug: Irbesartan (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (300 mg) after 14 days
Trial: 22002336
Drug: Aliskiren (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (300 mg) after 14 days
Trial: 9240180
Drug: Psychosocial intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychosocial intervention (weekly counselling 4-9 weeks after surgery)
Trial: 22109763
Drug: Antibiotic/steroid treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic/steroid treatment
Trial: 3908509
Drug: Modified Goeckerman
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Goeckerman regimen with hydrocortisone valerate cream
Trial: 3908509
Drug: Modified Goeckerman
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Goeckerman regimen with vehicle cream
Trial: 21323540
Drug: Conventional laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional laser therapy
Trial: 29680006
Drug: Intraprostatic injections
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAPROSTATIC LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraprostatic injections of onabotulinumtoxinA (200 U)
Trial: 24193238
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg (Group A)
Trial: 10599951
Drug: Deramciclane 30
RxNorm normalized name: Deramciclane
DrugBank: Deramciclane (DB06512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deramciclane 30 mg
Trial: 10599951
Drug: Deramciclane 60
RxNorm normalized name: Deramciclane
DrugBank: Deramciclane (DB06512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deramciclane 60 mg
Trial: 10760840
Drug: Deramciclane (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deramciclane (all doses)
Trial: 6289447
Drug: Prolonged course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged course of chemotherapy (41 weeks) combining adriamycin, methotrexate in high doses followed by folinic acid, vincristine, and cyclophosphamide
Trial: 30784924
Drug: Xinkeshu tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinkeshu tablets
Trial: 25534369
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose tDCS
Trial: 25534369
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose tDCS
Trial: 10347354
Drug: Crown type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crown type G (gold alloy)
Trial: 7493435
Drug: Antecedent hypoglycaemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antecedent hypoglycaemia (2.5 mmol/l)
Trial: 6244414
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose daily macrocrystals of nitrofurantoin
Trial: 6244414
Drug: Intravesical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical treatment and oral nitrofurantoin
Trial: 25991758
Drug: Protocolised algorithm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocolised algorithm using stroke volume variation to guide fluid administration
Trial: 23471488
Drug: Active pellets
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active pellets (5 g, 47% lauric acid by weight)
Trial: 19351658
Drug: Intranasal 350
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal 350 microg 17beta-estradiol + 550 microg norethisterone
Trial: 19351658
Drug: Intranasal 350
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal 350 microg 17beta-estradiol + 50 or 175 microg norethisterone
Trial: 19351658
Drug: Intranasal regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal regimens
Trial: 19351658
Drug: Oral 2
RxNorm normalized name: SYRINGE,ORAL 20ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 2 mg 17beta-estradiol + 1 mg norethisterone
Trial: 18006769
Drug: ABT‐510 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT‐510 10 mg twice daily
Trial: 18006769
Drug: ABT‐510 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT‐510 100 mg twice daily
Trial: 30378311
Drug: EGFR-TKIs plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGFR-TKIs plus Traditional Chinese Medicine (TCM)
Trial: 26944733
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg twice a day (D150)
Trial: 26944733
Drug: Dabigatran 110
RxNorm normalized name: dabigatran 110 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 110 mg twice a day (D110)
Trial: 16165400
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 1000 mg twice daily for 9 days
Trial: 28210808
Drug: Levalbuterol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levalbuterol (2.5 mg)
Trial: 12714797
Drug: Selegiline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline treatment
Trial: 6366823
Drug: Pentobarbitone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentobarbitone (100 mg)
Trial: 29774477
Drug: Cefepime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime (2 g q8h for adults and 50 mg/kg q8h for children)
Trial: 29774477
Drug: Cefoperazone/sulbactam plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone/sulbactam plus amikacin (CS + A) (2 g q8h for adults and 50 mg/kg q8h for children plus amikacin 15 mg/kg once a day)
Trial: 23901043
Drug: No steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No steroid treatment (Control)
Trial: 10068969
Drug: Ketoprofen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (1 mg W kg‐1)
Trial: 10068969
Drug: Pethidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine (1 mg W kg‐1)
Trial: 10068969
Drug: Saline (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.1 ml W kg‐1)
Trial: 8657963
Drug: Dry boldo
RxNorm normalized name: Boldo
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry boldo extract (2.5 g)
Trial: 1646369
Drug: Interferon alpha-2b
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alpha-2b treatment for 9 months
Trial: 30765762
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with calcium carbonate 300 mg daily
Trial: 30765762
Drug: Bushen Yijing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bushen Yijing Fang (BSYJF) with calcium carbonate 300 mg daily
Trial: 21550158
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) gel applied to the socket of the third molar
Trial: 19117316
Drug: OK-432 immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 immunotherapy (four-dose intralesional injection series at eight-week intervals)
Trial: 19117316
Drug: OK-432 immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 immunotherapy (for microcystic LM)
Trial: 19117316
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment group (observational controls)
Trial: 19117316
Drug: OK-432 immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 immunotherapy
Trial: 19117316
Drug: OK-432 immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 immunotherapy vs historical surgical data on LM
Trial: 1487229
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g propacetamol HCl given intravenously over a 15‐min period
Trial: 30854571
Drug: Light blue
RxNorm normalized name: opaspray light blue (TM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light blue gel nail polish using Masimo oximeter
Trial: 30854571
Drug: Orange gel
RxNorm normalized name: Octinoxate 2.5% Topical application Gel/Jelly [BAIN DE SOLEIL ORANGE GELEE]
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orange gel nail polish using Masimo oximeter
Trial: 30854571
Drug: Black gel
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black gel nail polish using Philips oximeter
Trial: 22699097
Drug: Forced-use therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forced-use therapy (FUT) program
Trial: 11836286
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg daily for 3 months, followed by 20 mg daily for 3 months)
Trial: 11836286
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg and 20 mg)
Trial: 10094169
Drug: Prednisolone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (20 mg b.i.d. IV/IM initially, decreasing over 40 days) with antituberculosis treatment
Trial: 10094169
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (antituberculosis treatment only)
Trial: 7593627
Drug: Inhaled methacholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled methacholine (increasing concentrations); no deep inspirations allowed
Trial: 7593627
Drug: Inhaled methacholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled methacholine (increasing concentrations); deep inspirations initiated
Trial: 2119303
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of phenytoin (PHT)
Trial: 11128246
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of carbamazepine (CBZ)
Trial: 2119303
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (continued existing therapy)
Trial: 27859395
Drug: 5-aminolevulinic acid
RxNorm normalized name: 5-aminolevulinic acid
DrugBank: Aminolevulinic acid (DB00855)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminolevulinic acid at a dosage of 10 mg/kg, administered 4-9 hours preoperatively
Trial: 27859395
Drug: 5-aminolevulinic acid
RxNorm normalized name: 5-aminolevulinic acid
DrugBank: Aminolevulinic acid (DB00855)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminolevulinic acid at a dosage of 1 mg/kg
Trial: 23906938
Drug: Calcineurin inhibitor
RxNorm normalized name: Calcineurin inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcineurin inhibitor and/or mycophenolate sodium (n=20)
Trial: 17367093
Drug: AVINZA (morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVINZA (morphine sulfate extended-release capsules)
Trial: 17367093
Drug: OxyContin (oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OxyContin (oxycodone hydrochloride controlled-release tablets)
Trial: 14644065
Drug: Progesterone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (200 mg, intramuscular injection)
Trial: 2468862
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nitrendipine (sublingually)
Trial: 2468862
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nifedipine (sublingually)
Trial: 27109450
Drug: Topiroxostat 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiroxostat 120 mg/day
Trial: 27109450
Drug: Allopurinol 200
RxNorm normalized name: allopurinol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 200 mg/day
Trial: 22141217
Drug: Fascia iliaca
RxNorm normalized name: OCTINOXATE .012 mL in 6 mL / OCTISALATE .12 mL in 6 mL TOPICAL CREAM [RIMMEL LONDON MOISTURE RENEW LIPGLOSS - FUSCIA THERAPHY (345)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fascia iliaca compartment block with 0.1% bupivacaine at a rate of 10 mL/h
Trial: 22141217
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural analgesia with 0.1% bupivacaine in continuous infusion at a rate of 8 mL/h
Trial: 16839319
Drug: Bremelanotide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bremelanotide (20 mg, single intranasal dose)
Trial: 12571655
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g American ginseng (AG)
Trial: 23303043
Drug: TC-5619 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TC-5619 (1 mg day 1 to week 4, 5 mg week 4 to 8, and 25 mg week 8 to 12)
Trial: 19105416
Drug: Velcade therapy
RxNorm normalized name: Velcade
DrugBank: Bortezomib D-mannitol (DB16741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Velcade therapy
Trial: 16406171
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of split, trivalent influenza vaccine
Trial: 16406171
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of split, trivalent influenza vaccine
Trial: 16406171
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of split, trivalent influenza vaccine (females)
Trial: 16406171
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of split, trivalent influenza vaccine (females)
Trial: 15592191
Drug: Dipyridamole (0.74
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (0.74 mg/kg) sestamibi imaging
Trial: 1867962
Drug: Intravenous cisapride
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cisapride 10 mg
Trial: 3691273
Drug: Oral cisapride
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cisapride 20 mg
Trial: 20040335
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) at a dose of 2 ‐ 3.5 g/m(2)
Trial: 29536782
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg of oxycodone (Group O)
Trial: 29536782
Drug: 1 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 µg/kg of fentanyl (Group F)
Trial: 19454920
Drug: Family-focused therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-focused therapy for adolescents (FFT-A)
Trial: 17436601
Drug: Low-dose step-up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose step-up OI protocol with weekly increments of 25 IU/day rFSH
Trial: 15545098
Drug: Botox injections
RxNorm normalized name: Botox
DrugBank: DaxibotulinumtoxinA (DB17929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botox injections (18 units per area) with ablative laser resurfacing
Trial: 8299664
Drug: Felodipine 20
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine 20 mg
Trial: 3415888
Drug: Saline by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline by infusion pump plus morphine 10 mg/70 kg s.c. (Control)
Trial: 29047215
Drug: 103 mg
RxNorm normalized name: valsartan 103 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 103 mg of p-synephrine (S)
Trial: 29047215
Drug: 233 mg
RxNorm normalized name: kava root 233 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 233 mg of caffeine + 104 mg of p-synephrine (LC + S)
Trial: 29047215
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg of caffeine (LC)
Trial: 29047215
Drug: 325 mg
RxNorm normalized name: lysine 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg of caffeine (HC)
Trial: 18447091
Drug: Breathing Awareness
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breathing Awareness Meditation (BAM), 10-minute sessions daily for three months
Trial: 14579656
Drug: Dimethindene maleate
RxNorm normalized name: dimethindene maleate
DrugBank: Dimetindene (DB08801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimethindene maleate (DMM) nasal spray for 2 weeks
Trial: 14579656
Drug: Dimethindene maleate
RxNorm normalized name: dimethindene maleate
DrugBank: Dimetindene (DB08801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimethindene maleate (DMM) nasal spray